Benzinga | May 13, 2021 11:33AM EDT

Rigel Therapeutics Files For U.S. Patent Titled 'HETEROCYCLIC RIP1 INHIBITORY COMPOUNDS'

https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220210139494%22.PGNR.&OS=DN/20210139494&RS=DN/20210139494